Anxiety symptoms

Active substance:

Content

Pharmacological groups

Nosological classification (ICD-10)

3D images

pharmachologic effect

Dosage and administration

Inside, after eating, drinking water, not chewing.

Asthenic and anxiety-neurotic states

Adults: 250–500 mg 3 times daily. Higher single doses: for adults – 750 mg, for patients over 60 years old – 500 mg. If necessary, increase the daily dose to 2.5 g (2500 mg). The course of treatment is 4-6 weeks.

Anxiety symptoms

Stuttering, tics and enuresis in children: from 8 to 14 years old – 250 mg 2-3 times a day; children older than 14 years – doses for adults.

Insomnia and night anxiety in the elderly: 250–500 mg 3 times a day.

Elimination of vertigo with vestibular analyzer dysfunction:

– of infectious genesis (otogenic labyrinthitis) and Meniere’s disease – in the period of exacerbation, 750 mg is prescribed 3 times a day for 5–7 days, while reducing the severity of vestibular disorders – 250–500 mg 3 times a day for 5–7 days, then – 250 mg / day for 5 days. With a relatively mild course of the disease – 250 mg 2 times a day for 5–7 days, then 250 mg / day for 7–10 days;

– vascular and traumatic genesis – 250 mg is prescribed 3 times a day for 12 days.

Prevention of motion sickness with kinetozakh

250–500 mg once a hour before the intended journey or when the first symptoms of motion sickness appear. Noofen’s counteracting effect is enhanced by increasing the dose of the drug. When the onset of pronounced manifestations of seasickness (in

As part of complex therapy for alcohol withdrawal syndrome for stopping psychopathological and somatovegetative disorders

In the first days of treatment, 250–500 mg is prescribed 3 times a day and 750 mg at night with a gradual decrease in the daily dose to the usual for adults.

Taking a double dose to replace the missed dose is unacceptable.

Patients with renal and / or hepatic insufficiency with prolonged use should monitor renal and / or liver function indicators.

In violation of the liver, high doses of the drug can cause hepatotoxicity. Patients are prescribed in smaller doses.

Release form

Capsules, 250 mg. 10 caps. in blister packaging made of PVC film and aluminum foil. On 2 blister packs in a pack of cardboard.

Manufacturer

JSC Olainfarm. St. Rupnitsa 5, Olaine, LV-2114, Latvia.

Claims of consumers to the representative office of JSC “Olainfarm” in the Russian Federation: 115193, Moscow, st. 7th Kozhukhovskaya, 20.

Pharmacy sales terms

Storage conditions of the drug Noofen ®

Keep out of the reach of children.

The shelf life of the drug Noofen ®

Do not use after the expiration date printed on the package.

Like this post? Please share to your friends:
Leave a Reply